New Key Statistics Module, Z-Score and F-Score
OTCPK:INNPF Key Ratios
| Market Cap $ M | 58.53 |
| Enterprise Value $ M | 54.67 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 13.57 |
| Price/Sales | 4.01 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 13.00 |
| EPS (TTM) $ | -0.02 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -4.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -13.70 |
| EV-to-EBITDA | -13.81 |
| PEG | -- |
| Shares Outstanding M | 280.66 |
| Net Margin (%) | -34.60 |
| Operating Margin % | -27.99 |
| Pre-tax Margin (%) | -29.72 |
| Quick Ratio | 1.99 |
| Current Ratio | 2.68 |
| ROA % (ttm) | -71.15 |
| ROE % (ttm) | -93.09 |
| ROIC % (ttm) | -201.56 |
| Dividend Yield % | -- |
| Altman Z-Score | 8.11 |
INNPF Number of Guru Trades
INNPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:INNPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:INNPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
InnoCan Pharma Corp Insider Transactions
No Available Data
News about OTCPK:INNPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers